Go to main content
Tillbaka till Back to integrum.se
SV EN

About Integrum

Integrum is a world leader in osseointegration – the process by which bone grows together with a titanium implant – for bone-anchored prostheses. Since its founding, Integrum's innovative OPRA™ system has contributed to improved quality of life for hundreds of people worldwide.

Improved mobility and function

Based on osseointegration, the bone-anchored implant system offers a range of benefits, including improved mobility and function, increased comfort, reduced pressure, a stable attachment, and more. The OPRA™ implant system was approved by the U.S. Food and Drug Administration (FDA) in 2020 and is the only FDA-approved bone-anchored implant system specifically designed for use by amputees available in the United States.

Press releases

Integrum’s press releases, regulatory news and other company updates for investors, media and the market.

To press releases

Financial reports

Here you will find Integrum’s quarterly reports, annual reports and year-end reports compiled for investors and the capital market.

To the reports
Cookies

This website uses cookiesfor statistics and user experience.

The website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website, and to offer more relevant offers to you.

Please read our privacy policy. If you consent to our use, select Allow all. If you want to change your choice later, you can find that option at the bottom of the page.